Advanced Therapies Integrates 2023
DEVELOPMENT, MANUFACTURE
& IMPLEMENTATION
Exploring the challenges in the journey to widespread adoption of ATMPs, from efficient manufacturing to streamlined NHS implementation.
FUNDING
& SKILLS
Looking at funding opportunities and strategies to overcome the sector-wide skills gap.
Registration and Networking
08:40 – 09:10
Registration and Networking
Welcome & Opening Remarks
09:10 – 09:20
Welcome & Opening Remarks
Sally Ann Forsyth OBE | Chief Executive Officer | Stevenage Bioscience Catalyst
Fireside Chat 1
09:20 – 09:40
Fireside Chat 1: Getting C> to the people who need them
With rapid innovations in the cell and gene therapy arena, how do we integrate breakthrough treatments into routine practice to ensure seamless access for the people living with potentially treatable conditions? How will improved access benefit both people receiving treatments and the wider community?
Speakers Include:
Nicola Redfern | Consultant | NJ Redfern Ltd
Samantha Barber | Chief Executive | Gene People
Neil Watson | Co-Director | Northern Alliance Advanced Therapies Treatment Centre
Fireside Chat 2
09:40 – 10:00
Fireside Chat 2
Speakers Include:
Matthew Durdy | Chief Executive Officer | Cell and Gene Therapy Catapult
Session 1
10:05 – 10.55
The right place at the right time
Manufacturing ATMPs requires advanced skills and expensive equipment. Does the UK system of science parks and innovation hubs support access to facilities and expertise?
We used to have more fun
The current economic environment is tough, especially when it comes to funding. When can we expect to see a return to previous levels of funding for the ATMP sector?
Session 2
11:00 – 11.50
Can we make them cheaper?
Advanced Therapies offer huge benefits, but often at a huge price tag. How can we improve standardisation and reduce the costs of manufacturing?
I got skills, they’re multiplying
Between 2021 and 2026, the UK advanced therapy and bioprocessing workforce is predicted to increase by over 100%. How can the industry and government work together to attract and retain the skills to support this growth?
Coffee Break
11:50 – 12:20
Networking coffee break
Session 3
12:20 – 13:10
You’re the Cell to my Gene
The right partner can help you ensure ATMP quality & safety and overcome financial & regulatory hurdles. How do you find the right cell & gene outsourcing partner, and how do you ensure this partnership is productive to both parties?
No Session in this Track
Please choose an alternative track
Lunch Break
13.10 – 14.10
Networking lunch break
Session 4
14.10 – 15.00
Not so rare after all
The first success of ATMPs has been seen in rare and complex diseases, but they have potential to go much further. How far and how fast can Advanced Therapies transition into more mainstream indications?
No Session in this Track
Please choose an alternative track
Session 5
15.05 – 15.55
An ATMP plan of action
With a 75 year old health service built around more ‘traditional’ methods of treatment, how can we ensure healthcare providers are supported and enabled to rapidly and effectively deploy Advanced Therapies?
No Session in this Track
Please choose an alternative track
Drinks Reception
15.55 – 16.55
Networking drinks reception
Sign up for life science integrates news
Get the latest news and updates by signing up today.
By signing up to the life science integrates newsletter, you have read and agree to our Privacy Policy, including our Cookie use.
Advanced Therapies Integrates 2023
Registration and Networking
08:40 – 09:10
Welcome & Opening Remarks
09.10 – 09.20
Sally Ann Forsyth OBE | Chief Executive Officer | Stevenage Bioscience Catalyst
Fireside Chat 1: Getting C> to the people who need them
With rapid innovations in the cell and gene therapy arena, how do we integrate breakthrough treatments into routine practice to ensure seamless access for the people living with potentially treatable conditions? How will improved access benefit both people receiving treatments and the wider community?
Speakers Include:
Nicola Redfern | Consultant | NJ Redfern Ltd
Samantha Barber | Chief Executive | Gene People
Neil Watson | Co-Director | Northern Alliance Advanced Therapies Treatment Centre
Fireside Chat 2
Speakers Include:
Matthew Durdy | Chief Executive Officer | Cell and Gene Therapy Catapult
TECHNICAL & PRODUCT
Session 1
10:05 – 10:55
The right place at the right time
Manufacturing ATMPs requires advanced skills and expensive equipment. Does the UK system of science parks and innovation hubs support access to facilities and expertise?
Session 2
11:00 – 11:50
Can we make them cheaper?
Advanced Therapies offer huge benefits, but often at a huge price tag. How can we improve standardisation and reduce the costs of manufacturing?
Coffee break & Networking
11:50 – 12:20
Session 3
12:20 – 13:10
You’re the Cell to my Gene
The right partner can help you ensure ATMP quality & safety and overcome financial & regulatory hurdles. How do you find the right cell & gene outsourcing partner, and how do you ensure this partnership is productive to both parties?
Lunch break & Networking
13:10 – 14:10
Session 4
14:10 – 15:00
Not so rare after all
The first success of ATMPs has been seen in rare and complex diseases, but they have potential to go much further. How far and how fast can Advanced Therapies transition into more mainstream indications?
Session 5
15:05 – 15:55
An ATMP plan of action
With a 75 year old health service built around more ‘traditional’ methods of treatment, how can we ensure healthcare providers are supported and enabled to rapidly and effectively deploy Advanced Therapies?
Networking drinks reception
15:55 – 16:55
COMMERCIAL, FINANCE
& MONEY
Session 1
10:05 – 10:55
We used to have more fun
The current economic environment is tough, especially when it comes to funding. When can we expect to see a return to previous levels of funding for the ATMP sector?
Session 2
11:00 – 11:50
I got skills, they’re multiplying
Between 2021 and 2026, the UK advanced therapy and bioprocessing workforce is predicted to increase by over 100%. How can the industry and government work together to attract and retain the skills to support this growth?
Coffee break & Networking
11:50 – 12:20
No session in this track – venue tour may be available
12:20 – 13:10
Lunch break & Networking
13:10 – 14:10
No session in this track – venue tour may be available
14:10 – 15:00
No session in this track – venue tour may be available
15:10 – 16:00
Networking drinks reception
16:00 – 16:55
Sign up for life science integrates news
Get the latest news and updates by signing up today.
By signing up to the life science integrates newsletter, you have read and agree to our Privacy Policy, including our Cookie use.